CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling

Guillaume Serwe(Institute for Research in Immunology and Cancer), Marc Therrien(Institute for Research in Immunology and Cancer)
Nature Communications
June 15, 2023
Cited by 9


Related Papers